Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Many users of weight loss medicines report hair loss as a side effect, but just how direct is the link between the two? And ...

Accordingly, GLP-1s have become the Mother’s Little Helper of Dallas real estate agents. “Lots of agents are on them,” ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

Zach Reitano discusses scaling GLP-1 care, tackling backlash, and what comes after weight-loss drugs go mainstream.

GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years ...

A recent study found that stopping GLP-1s, such as Ozempic or Wegovy, can reverse the cardiovascular benefits they provide.

Generic versions of semaglutide weight loss drugs like Ozempic and Wegovy are expected to launch in several countries ...

The comedian and actor, 49, said he took the weight-loss medication for five months ...

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.

“The bottom line I would convey to patients is that tried and true lifestyle interventions — adequate protein, fiber, ...